{
    "organizations": [],
    "uuid": "da4a8cfa89a0e17bedd879d1b342e2cb1d7364d3",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-eli-lillys-unit-bluegill-acquisiti/brief-eli-lillys-unit-bluegill-acquisition-offering-to-buy-all-of-armo-biosciencess-outstanding-shares-for-50-share-idUSFWN1SU0TE",
    "ord_in_thread": 0,
    "title": "BRIEF-Eli Lilly's Unit, Bluegill Acquisition Offering To Buy All Of Armo Biosciences's Outstanding Shares For $50/Share",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "May 23 (Reuters) - ARMO Biosciences Inc:\n* ARMO BIOSCIENCES - ELI LILLY’S UNIT, BLUEGILL ACQUISITION CORP, OFFERING TO BUY ALL OF CO’S OUTSTANDING SHARES FOR $50/SHARE - SEC FILING\n* ARMO BIOSCIENCES - ON APRIL 13, LILLY HAD DELIVERED PRELIMINARY INDICATION OF INTEREST REGARDING ACQUISITION OF CO FOR $55/SHARE Source text: ( bit.ly/2s7FKjY ) Further company coverage:\n ",
    "published": "2018-05-23T21:22:00.000+03:00",
    "crawled": "2018-05-24T20:27:33.018+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "may",
        "reuters",
        "armo",
        "bioscience",
        "inc",
        "armo",
        "bioscience",
        "eli",
        "lilly",
        "unit",
        "bluegill",
        "acquisition",
        "corp",
        "offering",
        "buy",
        "co",
        "outstanding",
        "share",
        "sec",
        "filing",
        "armo",
        "bioscience",
        "april",
        "lilly",
        "delivered",
        "preliminary",
        "indication",
        "interest",
        "regarding",
        "acquisition",
        "co",
        "source",
        "text",
        "company",
        "coverage"
    ]
}